Samsung Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
313
3,117
39,482
12,409
26,657
33,415
Total Accounts Receivable
37,923
14,353
15,156
19,089
23,401
33,388
Inventories
6,702
6,144
9,678
13,161
10,582
9,309
Other Current Assets
389
2,300
1,181
3,052
338
3,613
Total Current Assets
45,327
25,914
65,497
47,711
60,978
79,725
Net Property, Plant & Equipment
32,839
30,516
42,434
72,405
75,038
73,435
Total Investments and Advances
1,323
423
13,226
12,789
14,232
1,025
Long-Term Note Receivable
-
-
-
-
-
3,232
Intangible Assets
364
256
9,061
4,182
2,170
3,229
Other Assets
326
301
-
1,196
1,776
-
Total Assets
80,180
57,410
135,797
138,285
154,194
160,647
ST Debt & Current Portion LT Debt
20,400
22,642
20,434
27,876
40,461
Accounts Payable
15,318
4,661
2,721
4,285
6,211
Income Tax Payable
850
114
81
-
-
Other Current Liabilities
5,096
1,052
2,589
4,347
5,506
Total Current Liabilities
41,664
28,470
25,825
36,508
52,178
Long-Term Debt
17,984
3,506
54,231
18,671
6,291
Provision for Risks & Charges
1,688
2,179
2,550
2,897
3,114
Deferred Taxes
-
-
1,298
67
-
Other Liabilities
102
72
77
127
127
Total Liabilities
61,438
34,226
89,560
58,270
61,711
Common Equity (Total)
18,741
23,184
46,237
80,015
92,483
Total Shareholders' Equity
18,741
23,184
46,237
80,015
92,483
Total Equity
18,741
23,184
46,237
80,015
92,483
Liabilities & Shareholders' Equity
80,180
57,410
135,797
138,285
154,194
Accumulated Minority Interest
-
-
-
-
-
About Samsung Pharmaceutical Co.
View Profile
